Skip to main content

Search

Reset all filters
848 Result(s)
Sort by

Why cancer care is personal for us

Why cancer care is personal for us

At Boehringer Ingelheim, we have made a generational commitment to transforming cancer care, with the ultimate goal of curing a range of cancers.
Targeting HER2 in cancer

Targeting HER2 in cancer

Our cancer researchers share insights into the discovery of our investigational HER2-selective tyrosine kinase inhibitor.
Board of Managing Directors

Board of Managing Directors

Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities.
Office Hours Program | Partnering

Office Hours Program | Partnering

Click here to find out how Boehringer Ingelheim's pioneering ‘Office Hours’ program has now mentored over 250 early-stage companies since 2015.
Top-line Phase II Data for treatment of MASH

Top-line Phase II Data for treatment of MASH

Boehringer Ingelheim and Zealand Pharma announced top-line Phase II data for treatment of metabolic dysfuntion-associated steatohepatitis (MASH).
More Health Overview

More Health Overview

Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations.
Valerie Nock

Valerie Nock

My career challengeFunctional Areas at Boehringer Ingelheim
Work life balance

Work life balance

It is important that employees have a balance between professional and personal lives, so we offer various leave options and flexible working schedules.
Clinical Development and Operations

Clinical Development and Operations

Click here to find out more on how Boehringer Ingelheim is proud to offer a new 2-year Fellowship program within Clinical Operations.
Something learnt

Something learnt

We know that to really thrive as a company, we have to help our teams to continue to grow in their careers. Here are some of things they have learnt at work.